OMB
.report
Search
Final Guidance For User Fees 8-28-14
Registration of Human Drug Compounding Outsourcing Facilities under section 503B of the FFDCA and Associated fees under section 744K
FINAL GUIDANCE FOR USER FEES 8-28-14
OMB: 0910-0776
OMB.report
HHS/FDA
OMB 0910-0776
ICR 202311-0910-015
IC 212975
Final Guidance For User Fees 8-28-14
( )
Document [doc]
Download:
doc
|
pdf
File Type
inode/x-empty
© 2024 OMB.report |
Privacy Policy